BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 35863587)

  • 21. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allosteric modulation of G protein-coupled receptors by amiloride and its derivatives. Perspectives for drug discovery?
    Massink A; Amelia T; Karamychev A; IJzerman AP
    Med Res Rev; 2020 Mar; 40(2):683-708. PubMed ID: 31495942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allosteric modulation of G protein-coupled receptors.
    May LT; Avlani VA; Sexton PM; Christopoulos A
    Curr Pharm Des; 2004; 10(17):2003-13. PubMed ID: 15279541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
    Conn PJ; Christopoulos A; Lindsley CW
    Nat Rev Drug Discov; 2009 Jan; 8(1):41-54. PubMed ID: 19116626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of Mixed-Solvent Molecular Dynamics Simulations for Prediction of Allosteric Sites on G Protein-Coupled Receptors.
    Chan WKB; Carlson HA; Traynor JR
    Mol Pharmacol; 2023 May; 103(5):274-285. PubMed ID: 36868791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Covalent allosteric modulation: An emerging strategy for GPCRs drug discovery.
    Bian Y; Jun JJ; Cuyler J; Xie XQ
    Eur J Med Chem; 2020 Nov; 206():112690. PubMed ID: 32818870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of new GPCR ligands to illuminate new biology.
    Roth BL; Irwin JJ; Shoichet BK
    Nat Chem Biol; 2017 Nov; 13(11):1143-1151. PubMed ID: 29045379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging paradigms in GPCR allostery: implications for drug discovery.
    Wootten D; Christopoulos A; Sexton PM
    Nat Rev Drug Discov; 2013 Aug; 12(8):630-44. PubMed ID: 23903222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G-protein coupled receptors: advances in simulation and drug discovery.
    Miao Y; McCammon JA
    Curr Opin Struct Biol; 2016 Dec; 41():83-89. PubMed ID: 27344006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders.
    Lütjens R; Rocher JP
    Curr Opin Pharmacol; 2017 Feb; 32():91-95. PubMed ID: 28135635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric modulation of G protein-coupled receptor signaling.
    Shen S; Zhao C; Wu C; Sun S; Li Z; Yan W; Shao Z
    Front Endocrinol (Lausanne); 2023; 14():1137604. PubMed ID: 36875468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying novel modulators of G protein-coupled receptors via interaction at allosteric sites.
    Presland J
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):567-76. PubMed ID: 16159018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Harnessing Ion-Binding Sites for GPCR Pharmacology.
    Zarzycka B; Zaidi SA; Roth BL; Katritch V
    Pharmacol Rev; 2019 Oct; 71(4):571-595. PubMed ID: 31551350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unmasking allosteric-binding sites: novel targets for GPCR drug discovery.
    Casadó-Anguera V; Casadó V
    Expert Opin Drug Discov; 2022 Aug; 17(8):897-923. PubMed ID: 35649692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a common allosteric binding site for G-protein coupled receptors?
    Malik F; Li Z
    J Comput Aided Mol Des; 2022 Jun; 36(6):405-413. PubMed ID: 35507106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allosteric modulation of G-protein coupled receptors.
    Jensen AA; Spalding TA
    Eur J Pharm Sci; 2004 Mar; 21(4):407-20. PubMed ID: 14998571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms.
    Bridges TM; Lindsley CW
    ACS Chem Biol; 2008 Sep; 3(9):530-41. PubMed ID: 18652471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs.
    Congreve M; Oswald C; Marshall FH
    Trends Pharmacol Sci; 2017 Sep; 38(9):837-847. PubMed ID: 28648526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.
    Slosky LM; Caron MG; Barak LS
    Trends Pharmacol Sci; 2021 Apr; 42(4):283-299. PubMed ID: 33581873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small Molecule Tools to Study Cellular Target Engagement for the Intracellular Allosteric Binding Site of GPCRs.
    Huber ME; Toy L; Schmidt MF; Weikert D; Schiedel M
    Chemistry; 2023 Jan; 29(1):e202202565. PubMed ID: 36193681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.